Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7N8I | 7N8I | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) | |
| 7N8H | P0DTC2 | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 7N8H | 7N8H | SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement | |
| 7N8D | P47929 | Crystal structure of R22A human Galectin-7 mutant in presence of Lactose | |
| 7N86 | Q9BYE9 | Crystal Structure of Human Protocadherin-24 EC1-2 Form II | |
| 7N78 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the E2-Pi state | |
| 7N72 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the AlF-bound E2-Pi-like state | |
| 7N70 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the BeF-bound E2P-like state | |
| 7N6W | Q75760 | Structure of uncleaved HIV-1 JR-FL Env glycoprotein trimer in state U2 bound to small Molecule HIV-1 Entry Inhibitor BMS-378806 | |
| 7N6U | Q75760 | Structure of uncleaved HIV-1 JR-FL Env glycoprotein trimer in state U1 bound to small Molecule HIV-1 Entry Inhibitor BMS-378806 | |
| 7N6O | G8LU16 | The crystal structure of the GH30 subfamily 10 enzyme, AcXbh30A from Acetivibrio clariflavus in complex with xylobiose | |
| 7N65 | A0A6H1VCM1 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
| 7N65 | Q2N0S7 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
| 7N65 | 7N65 | Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664 | |
| 7N64 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
| 7N64 | 7N64 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) | |
| 7N62 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
| 7N62 | 7N62 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
| 7N5H | P0DTC2 | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7N5H | 7N5H | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7N57 | P47929 | Crystal structure of R20A human Galectin-7 mutant in presence of lactose | |
| 7N4Y | A0A4W2CHS8 | The structure of bovine thyroglobulin with iodinated tyrosines | |
| 7N4X | Q9UHC9 | Structure of human NPC1L1 mutant-W347R | |
| 7N4V | Q9UHC9 | Structure of cholesterol-bound human NPC1L1 | |
| 7N4U | Q9UHC9 | Structure of human NPC1L1 | |
| 7N4M | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
| 7N4M | 7N4M | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
| 7N4J | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
| 7N4J | 7N4J | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
| 7N4I | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
| 7N4I | 7N4I | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
| 7N3T | P04629 | TrkA ECD complex with designed miniprotein ligand | |
| 7N3T | 7N3T | TrkA ECD complex with designed miniprotein ligand | |
| 7N3I | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
| 7N3I | 7N3I | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
| 7N2S | A3F718 | AS3.1-PRPF3-HLA*B27 | |
| 7N2S | P61769 | AS3.1-PRPF3-HLA*B27 | |
| 7N2S | 7N2S | AS3.1-PRPF3-HLA*B27 | |
| 7N2R | A3F718 | AS4.3-PRPF3-HLA*B27 | |
| 7N2R | P61769 | AS4.3-PRPF3-HLA*B27 | |
| 7N2R | 7N2R | AS4.3-PRPF3-HLA*B27 | |
| 7N2Q | A3F718 | AS4.3-YEIH-HLA*B27 | |
| 7N2Q | P61769 | AS4.3-YEIH-HLA*B27 | |
| 7N2Q | 7N2Q | AS4.3-YEIH-HLA*B27 | |
| 7N2P | A3F718 | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2P | P61769 | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2P | 7N2P | AS4.3-RNASEH2b-HLA*B27 | |
| 7N2O | A3F718 | AS4.2-YEIH-HLA*B27 | |
| 7N2O | P61769 | AS4.2-YEIH-HLA*B27 | |
| 7N2O | 7N2O | AS4.2-YEIH-HLA*B27 |
